Abstracts by keywords: short-term psychotherapy
On June 16, 2016, the G-BA created new framework conditions for low-threshold therapy offers with the structural reform of outpatient psychotherapy, which has been in effect since April 1, 2017. The declared aim of the reform is to make psychotherapeutic care more effective, including reducing waiting times. Psychotherapeutic consultations, acute psychotherapeutic treatment and relapse prevention as new elements of care are intended to ensure flexible, low-threshold and timely access to psychotherapy. Acute treatment plays an important role in the reform. It should be carried out as a short-term intervention with a maximum of 24 sessions lasting 25 minutes each (G-BA 2017, p.7). These “new care offers” will diversify the range of services for mentally ill people, i.e. expand the variety of offers in this care area. The G-BA is currently also examining the inclusion of systemic therapy in standard care, for which IQWIG, which was commissioned to do this, published a preliminary benefit assessment on August 16, 2016 (IQWIG 2016), while many health insurance companies are working with specialized providers such as Ge.on Case Management GmbH is already improving the care of mentally ill patients.1 In addition, there are a number of so-called digital mental health programs, some of which have also made the jump to reimbursement by statutory health insurance, for example Deprexis or Novego2, others will follow here. With an increasingly differentiated supply of care, knowledge of the study situation and, as a result, the control and coordination function of providers and health insurance companies is becoming increasingly relevant. Therefore, both the psychotherapeutic consultation hours on the part of the providers and the offering of managed care providers on the part of the consumers will assume a very central control function in the future. As part of this article, Ge.on Case Management GmbH has therefore investigated the question of what benefits of short-term psychotherapeutic interventions have so far been proven in randomized controlled trials (RCT), whether there are any statements about the cost-effectiveness of such procedures and how the care situation in Germany compares internationally represents comparison.